" /> Type 7: Separate Products Requiring Cross Labeling - CISMeF





Preferred Label : Type 7: Separate Products Requiring Cross Labeling;

NCIt definition : Products meeting the definition at 21 CFR 3.2(e)(3) or (4) comprised of a separately marketed drug, device, and/ or biological product, such as certain light-activated drugs and associated light sources.;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.